NCT02420223View on ClinicalTrials.gov

Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 17, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

February 29, 2020

Conditions
Multiple Myeloma
Interventions
DRUG

Propranolol

Trial Locations (1)

53226

Froedtert Hospital and the Medical College of Wisconsin, Milwaukee

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

Medical College of Wisconsin

OTHER

NCT02420223 - Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients | Biotech Hunter | Biotech Hunter